Both the S&P 500 and Nasdaq Composite indexes are hovering around all-time highs. Unsurprisingly, a euphoric narrative ...

Meta's operating performance has been incredibly strong over the past year, thanks partly to its investments in AI, so its ...

Nvidia owns a 7% stake in CoreWeave, and made it possible for the young company to be the first to launch its latest GPUs. In ...

About This EventADMA Biologics, Inc. (Nasdaq: ADMA), a U.S. based, end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty biologics, visits the ...

Palantir's expansion into commercial markets has boosted its business. The stock has been on a tear since the start of 2024.

One stock that managed to outmaneuver the various headwinds torturing the markets throughout the year, however, is data ...

About This EventArtiva Biotherapeutics (Nasdaq: ARTV), visits the Nasdaq MarketSite in Times Square. Artiva is a clinical-stage biotechnology company whose mission is to develop effective, safe, and ...

Although Alibaba stock looks reasonably priced, Amazon's lower business risk from the U.S.-China tensions gives it the edge ...

Google parent Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) looks like an absolute steal compared to Palantir. While Palantir's forward price-to-earnings ratio is a jaw-dropping 256.4, Alphabet's shares ...

With shares down 21% year to date, Tesla (NASDAQ: TSLA) is reeling from a combination of weakening electric vehicle (EV) ...

Palantir bulls point to this as a reason why the stock could reach a $1 trillion valuation by 2035. However, the bears have ...